Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis.
Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.
Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma.
Screening, Brief Intervention, and Referral to Treatment for Pain Management for Veterans Seeking Service-Connection Payments for Musculoskeletal Disorders: SBIRT-PM Study Protocol.
Emerging medical therapies for severe alcoholic hepatitis.
See All 20 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Emerging medical therapies for severe alcoholic hepatitis.
Tornai D, Szabo G. Emerging medical therapies for severe alcoholic hepatitis. Clin Mol Hepatol. 2020 10; 26(4):686-696.
View in:
PubMed
subject areas
End Stage Liver Disease
Hepatitis, Alcoholic
Humans
Inflammation
Severity of Illness Index
authors with profiles
Gyongyi Szabo MD, PhD